[{"orgOrder":0,"company":"Letco Medical","sponsor":"Specialty Process Labs","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"","productType":"Large molecule","year":"2021","type":"Partnership","leadProduct":"Thyroid","moa":"","graph1":"Endocrinology","graph2":"Approved","graph3":"Letco Medical","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Powder Extract","sponsorNew":"Letco Medical \/ Letco Medical","highestDevelopmentStatusID":"12","companyTruncated":"Letco Medical \/ Letco Medical"}]

Find Clinical Drug Pipeline Developments & Deals by Letco Medical

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharmtech & Ingredients
                          Not Confirmed
                          Pharmtech & Ingredients
                          Not Confirmed

                          Details : Under the partnership with SPL Labs, Letco Medical has authorized it as US distributor of Thyroid USP for compounding pharmacies. Letco was attracted to SPL Labs because its porcine ingredients and is the only API manufacturer to produce Thyroid USP in U...

                          Brand Name : Thyroid (USP)

                          Molecule Type : Large molecule

                          Upfront Cash : Undisclosed

                          November 03, 2021

                          Lead Product(s) : Thyroid

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Approved

                          Recipient : Specialty Process Labs

                          Deal Size : Undisclosed

                          Deal Type : Partnership

                          blank